EUNICE PARK: Open Payments
NPI 1366911604 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 84 payments from 15 companies in 2025. Trend: 2023 $1,377 · 2024 $1,697 · 2025 $1,270
Food & beverage: $1,260Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $411 |
| Novartis Pharmaceuticals Corporation | 15 | $171 |
| Amgen Inc. | 10 | $149 |
| GENZYME CORPORATION | 6 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $119 |
| Arcutis Biotherapeutics, Inc. | 4 | $61 |
| UCB, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| PFIZER INC. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: SKYRIZI, DUPIXENT, OTEZLA, COSENTYX, ILUMYA, RINVOQ, Zoryve, Bimzelx.
Industry payments across WA — which companies pay providers there.
